1
|
Interactions of Comorbidity and Five Simple Environmental Unhealthy Habits Concerning Physical and Mental Quality of Life in the Clinical Setting. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph18189590. [PMID: 34574515 PMCID: PMC8467323 DOI: 10.3390/ijerph18189590] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 09/02/2021] [Accepted: 09/08/2021] [Indexed: 12/19/2022]
Abstract
The objective of this study was to examine the interactions between comorbidity and five lifestyle single habits concerning different subscales of quality of life (QoL). For the study, 302 patients were consecutively recruited at the internal medicine department of a tertiary teaching hospital. Lifestyle habits, comorbidities and QoL were recorded according to validated questionnaires. Five single unhealthy habits, such as tobacco consumption, dietary intake of ultra-processed pastries, raw nuts or carbonated drinks, sleep time and physical activity patterns were selected according to previously published data. The main outcomes of the study were the scores of the eight subscales of the SF-36 QoL survey. The aggregate of unhealthy habits showed statistically significant association to every category in the SF-36 questionnaire, both in the univariate and the multivariate analysis when adjusting by age, sex and comorbidity. An interaction was found between comorbidity and unhealthy habits in both physical and mental summaries of SF-36. In conclusion, the lifestyle assessment according to five unhealthy habits is associated with a worse QoL. The interaction between comorbidity and unhealthy habits is especially clear in diseased patients due to the interplay between illness and lifestyle in the prediction of QoL.
Collapse
|
2
|
Martinez-Urbistondo D, Suarez del Villar R, Argemí J, Daimiel L, Ramos-López O, San-Cristobal R, Villares P, Martinez JA. Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis. Antioxidants (Basel) 2020; 9:antiox9111125. [PMID: 33202851 PMCID: PMC7696605 DOI: 10.3390/antiox9111125] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2020] [Revised: 11/07/2020] [Accepted: 11/09/2020] [Indexed: 12/16/2022] Open
Abstract
The assessment of liver fibrosis has gained importance since the progression of non-alcoholic fatty liver disease (NAFLD). Indeed, the description of the association between undetected liver fibrosis and lifestyle in terms of antioxidant habits, comorbidity and quality of life (QoL) domains may help in the characterization of subjects with NAFLD. A cross-sectional evaluation of (n = 116) consecutive patients from an Internal Medicine ambulatory evaluation was performed. Demographic data, lifestyle, co-morbidity, QoL (according to the SF-36 index) and analytical values to calculate the oxidative related Fibrosis-4 (FIB-4) index were recorded. The association between FIB-4 and co-morbidity, antioxidant habits in QoL was assessed in univariate analysis (p < 0.05) and confirmed in multivariable analysis for 4 of the 8 SF-36 categories: Physical QoL, Physical role, Social QoL and General QoL, as well as in the Physical summary of SF-36 (p < 0.05). Finally, interactions were assessed between co-morbidity, FIB-4 and antioxidant habits showed in the prediction of mean SF-36 (p < 0.01). Liver fibrosis assessed by the oxidative surrogate index FIB-4 is associated with the interaction between antioxidant lifestyle, co-morbidity and physical, social and general aspects of QoL in apparent liver disease-free individuals, generating a proof of concept for health empowerment and personalized medicine.
Collapse
Affiliation(s)
- Diego Martinez-Urbistondo
- Internal Medicine Department, Hospital HM Sanchinarro, HM Hospitales, 28050 Madrid, Spain; (R.S.d.V.); (P.V.)
- Correspondence:
| | - Rafael Suarez del Villar
- Internal Medicine Department, Hospital HM Sanchinarro, HM Hospitales, 28050 Madrid, Spain; (R.S.d.V.); (P.V.)
| | - Josepmaria Argemí
- Liver Unit, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, 31008 Pamplona, Spain;
| | - Lidia Daimiel
- Precision Nutrition Program, Instituto Madrileño de Estudios Avanzados, Universidad Autónoma de Madrid, 28049 Madrid, Spain; (L.D.); (R.S.-C.); (J.A.M.)
| | - Omar Ramos-López
- Medicine and Psychology School, Autonomous University of Baja California, Tijuana 22390, Mexico;
| | - Rodrigo San-Cristobal
- Precision Nutrition Program, Instituto Madrileño de Estudios Avanzados, Universidad Autónoma de Madrid, 28049 Madrid, Spain; (L.D.); (R.S.-C.); (J.A.M.)
| | - Paula Villares
- Internal Medicine Department, Hospital HM Sanchinarro, HM Hospitales, 28050 Madrid, Spain; (R.S.d.V.); (P.V.)
| | - Jose Alfredo Martinez
- Precision Nutrition Program, Instituto Madrileño de Estudios Avanzados, Universidad Autónoma de Madrid, 28049 Madrid, Spain; (L.D.); (R.S.-C.); (J.A.M.)
- CIBERobn: Fisiopatología de la Obesidad y Nutrición, Instituto Carlos III, 28029 Madrid, Spain
| |
Collapse
|